Psychologic factors in psoriasis: Consequences, mechanisms, and interventions

Dermatologic Clinics

Volumn 23, Issue 4 SPEC. ISS., 2005, Pages 681-694

  Fortune, Dónal G ^a   Richards, Helen L ^b,c   Griffiths, Christopher E M ^b  

^a HOPE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEXITHYMIA; ANXIETY; BEHAVIORAL SCIENCE; COGNITIVE THERAPY; DEPRESSION; DERMATOLOGY; DISABILITY; DISEASE SEVERITY; EMOTIONAL STABILITY; FAMILY; HUMAN; HUMAN RELATION; MEDICAL LITERATURE; MEDICAL RESEARCH; MENTAL STRESS; PATIENT COUNSELING; PATIENT EDUCATION; PERCEPTION; PERSONALITY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; SOCIAL ASPECT; SOCIAL PSYCHOLOGY;

EID: 23844554550     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2005.05.022     Document Type: Review

References (121)

1. I.H. Ginsburg Psychological and psychophysiological aspects of psoriasis Dermatol Clin North Am 13 1995 793 804
2. D.G. Fortune, H.L. Richards, and C.J. Main Pathological worrying, illness perceptions, and disease severity in patients with psoriasis Br J Heal Psychol 5 2000 71 82
3. D.G. Fortune, H.L. Richards, and C.J. Main What patients with psoriasis believe about their condition J Am Acad Dermatol 39 1998 197 201
4. G. Krueger, J. Koo, and M. Lebwohl The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient membership survey Arch Dermatol 137 2001 280 284
5. G.J. Nevitt, and P.E. Hutchinson Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease Br J Dermatol 135 1996 533 537
6. C.J. O'Leary, D. Creamer, and E. Higgins Perceived stress attributions and psychological stress in psoriasis J Psychosom Res 57 2004 465 471
7. R. Zachariae, H. Zachariae, and K. Blomqvist Self-reported stress reactivity and psoriasis-related stress of Nordic psoriasis sufferers J Eur Acad Dermatol Venereol 18 2004 27 36
8. B. Kirby, H.L. Richards, and P. Woo Physical and psychologic measures are necessary to assess overall psoriasis severity J Am Acad Dermatol 45 2001 72 76
9. A.Y. Finlay, and E.C. Coles The effect of severe psoriasis on the quality of life of 369 patients Br J Dermatol 132 1995 236 244
10. A. Picardi, P. Amerio, and G. Baliva Recognition of depressive and anxiety disorders in dermatological outpatients Acta Derm Venereol 84 2004 213 217
11. A. Picardi, D. Abeni, and C.F. Melchi Psychiatric morbidity in dermatological outpatients: an issue to be recognised Br J Dermatol 143 2000 983 991
12. A. Picardi, D. Abeni, and C. Renzi Increased psychiatric morbidity in female outpatients with skin lesions on visible parts of the body Acta Derm Venereol 81 2001 410 414
13. H.L. Richards, D.G. Fortune, and A. Weidman Detection of psychological distress in patients with psoriasis-low consensus between doctor and patient Br J Dermatol 151 2004 1227 1233
14. C. Renzi, A. Picardi, and D. Abeni Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance Arch Dermatol 138 2002 337 342
15. H.L. Richards, D.G. Fortune, and T.M. O'Sullivan Patients with psoriasis and their compliance with medication J Am Acad Dermatol 41 1999 581 583
16. D.G. Fortune, H.L. Richards, and B. Kirby Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy (PUVA) Arch Dermatol 139 2003 752 756
17. F. Sampogna, A. Picardi, and C.F. Melchi The impact of skin diseases on patients: comparing dermatologists' opinions with research data collected on their patients Br J Dermatol 148 2003 989 995
18. S.R. Feldman, A.B. Fleischer, and D.M. Reboussin The self-administered psoriasis area and severity index is valid and reliable J Invest Dermatol 106 1996 183 186
19. A.B. Fleischer, S.R. Feldman, and S.R. Rapp Disease severity measures in a population of psoriasis patients: the symptoms of psoriasis correlate with self administered Psoriasis Area and Severity Index Scores J Invest Dermatol 107 1996 26 29
20. D.G. Fortune, C.J. Main, and T.M. O'Sullivan Quality of life in psoriasis: the contribution of clinical variables and psoriasis-specific stress Br J Dermatol 137 1997 755 760
21. N. Jenner, J. Campbell, and A. Plunkett Cost of psoriasis: a study on the morbidity and financial effects of having psoriasis in Australia Austral J Dermatol 43 2002 255 261
22. B. Kirby, D.G. Fortune, and M. Bhushan The Salford Psoriasis Index: an holistic measure of psoriasis severity Br J Dermatol 142 2000 728 732
23. C.J. Main, H.L. Richards, and D.G. Fortune Why put new wine in old bottles: the need for a biopsychosocial approach to the assessment, treatment, and understanding of unexplained and explained symptoms in medicine J Psychosom Res 48 2000 511 514
24. M.B. Nichol, J.E. Margolies, and E. Lippa The application of multiple quality-of-life instruments in individuals with mild-to-moderate psoriasis Pharmacoeconom 10 1996 644 653
25. S.B. Perrott, A.H. Murray, and J. Lowe The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatization Physiol Behav 70 2000 567 571
26. F. Sampogna, A. Picardi, and M.M. Chren Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions Psychosom Med 66 2004 620 624
27. F. Sampogna, F. Sera, and D. Abeni IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) investigators: measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis J Invest Dermatol 122 2004 602 607
28. A. Wahl, T. Moum, and B.R. Hanestad The relationship between demographic and clinical variables, and quality of life aspects in patients with psoriasis Qual Life Res 8 1999 319 326
29. R. Zachariae, H. Zachariae, and K. Blomqvist Quality of life in 6497 Nordic patients with psoriasis Br J Dermatol 146 2002 1006 1016
30. R.G. Fried, S. Friedman, and C. Paradis Trivial or terrible? The psychosocial impact of psoriasis Int J Dermatol 34 1995 101 105
31. G. Kiebert, S.V. Sorensen, and D. Revicki Atopic dermatitis is associated with a decrement in health-related quality of life Int J Dermatol 41 2002 151 158
32. S.R. Rapp, S.R. Feldman, and M.L. Exum Psoriasis causes as much disability as other major medical diseases J Am Acad Dermatol 41 1999 401 407
33. P. O'Neill, and P. Kelly Postal questionnaire study of disability in the community associated with psoriasis BMJ 313 1996 919 921
34. D. Vardy, A. Besser, and M. Amir Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients Br J Dermatol 147 2002 736 742
35. A. Wahl, J.H. Loge, and I. Wiklund The burden of psoriasis: a study concerning health-related quality of life among Norwegian adult patients with psoriasis compared with general population norms J Am Acad Dermatol 43 2000 803 808
36. A.K. Wahl, E. Gjengedal, and B.R. Hanestad The bodily suffering of living with severe psoriasis: In-depth interviews with 22 hospitalized patients with psoriasis Qual Health Res 12 2002 250 261
37. C.M. Clark, R.A. McKay, and D.G. Fortune Use of alternative treatments by patients with psoriasis Br J Gen Pract 48 437 1998 1873 1874
38. L. Lundberg, M. Johannesson, and M. Silverdahl Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema Br J Dermatol 141 1999 1067 1075
39. T.E. Poyner, and P.J. Fell A survey of patients with plaque psoriasis who had not consulted their doctor in the past year Br J Clin Res 6 1995 201 207
40. D. Harlow, T. Poyner, and A.Y. Finlay Impaired quality of life of adults with skin disease in primary care Br J Dermatol 143 2000 979 982
41. E.M. de Jong, B.A. Seegers, and M.K. Gulinck Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients Dermatology 193 1996 300 303
42. A.A. Pettey, R. Balkrishnan, and S.R. Rapp Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implications for clinical practice J Am Acad Dermatol 49 2003 271 275
43. H. Zachariae, R. Zachariae, and K. Blomqvist Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations: data from the Nordic Quality of Life Study Acta Derm Venereol 82 2002 108 113
44. J.A. Husted, D.D. Gladman, and V.T. Farewell Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis J Rheumatol 24 1997 511 517
45. K.E. McKenna, and R.S. Stern The impact of psoriasis on the quality of life of patients from the 16-center PUVA follow-up cohort J Am Acad Dermatol 36 1997 388 394
46. M.A. Gupta, and A.K. Gupta Age and gender differences in the impact of psoriasis on quality of life Int J Dermatol 34 1995 700 703
47. J.M. Gelfand, S.R. Feldman, and R.S. Stern Patients with more extensive psoriasis have greater reductions in quality of life: female patients and young patients are affected to a greater extent J Invest Dermatol 122 2004 60
48. E. Mazzotti, A. Picardi, and F. Sampogna Sensitivity of the Dermatology Life Quality Index to clinical change in patients with psoriasis Br J Dermatol 149 2003 318 322
49. M. Lebwohl, E. Christophers, and R. Langley An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular Alefacept in patients with chronic plaque psoriasis Arch Dermatol 139 2003 719 727
50. M.S. Salek, A.Y. Finlay, and J.J. Lewis Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral) Qual Life Res 13 2004 91 95
51. C.R. Touw, L. Hakkaart-Van Roijen, and P. Verboom Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin Br J Dermatol 144 2001 967 972
52. C.N. Ellis, M.M. Mordin, and E.Y. Adler Randomized, placebo-controlled phase II trial: effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trial Am J Clin Dermatol 4 2003 131 139
53. D.G. Fortune, H.L. Richards, and K. McElhone Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-being Br J Dermatol 151 2004 1219 1226
54. G. Gupta, J. Long, and D.M. Tillman The efficacy of narrowband ultraviolet B phototherapy in psoriasis using objective and subjective outcome measures Br J Dermatol 140 1999 887 890
55. H.L. Richards, D.G. Fortune, and C.E.M. Griffiths The contribution of perceptions of stigmatisation to disability in patients with psoriasis J Psychosom Res 50 2001 11 15
56. L. Hill, and P. Kennedy The role of coping strategies in mediating subjective disability in people who have psoriasis Psychol Health Med 7 2002 261 269
57. D.G. Fortune, C.J. Main, and T.M. O'Sullivan Assessing illness-related stress in psoriasis: the psychometric properties of the Psoriasis Life Stress Inventory J Psychosom Res 42 1997 467 476
58. D. Metz, and G.B.E. Jemec Coping and psoriasis-a framework for targeted interventions J Eur Acad Dermatol Venereol 6 1996 27 31
59. A. Wahl, B.R. Hanestad, and I. Wiklund Coping and quality of life in patients with psoriasis Qual Life Res 8 1999 427 433
60. M. Scharloo, A.A. Kaptein, and J. Weinman Illness perceptions, coping and functioning in patients with rheumatoid arthritis, chronic obstructive pulmonary disease and psoriasis J Psychosom Res 44 1998 573 585
61. M. Scharloo, A.A. Kaptein, and J. Weinman Patients' illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up Br J Dermatol 142 2000 899 907
62. D.G. Fortune, H.L. Richards, and C.J. Main Patients' strategies for coping with psoriasis Clin Exp Dermatol 127 2002 177 185
63. S.R. Rapp, C.A. Cottrell, and M.R. Leary Social coping strategies associated with quality of life decrements among psoriasis patients Br J Dermatol 145 2001 610 616
64. A. Akay, A. Pekcanlar, and K.E. Bozdag Assessment of depression in subjects with psoriasis vulgaris and lichen planus J Eur Acad Dermatol Venereol 16 2002 347 352
65. H. Devrimci-Ozguven, T.N. Kundakci, and H. Kumbasar The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients J Eur Acad Dermatol Venereol 14 2000 267 271
66. S. Bharath, C. Shamasundar, and R. Raghuram Psychiatric morbidity in leprosy and psoriasis-a comparative study Ind J Leprosy 69 1997 341 346
67. S.K. Mattoo, S. Handa, and I. Kaur Psychiatric morbidity in vitiligo and psoriasis: a comparative study from India J Dermatol 28 2001 424 432
68. N. Sharma, R.V. Koranne, and R.K. Singh Psychiatric morbidity in psoriasis and vitiligo: a comparative study J Dermatol 28 2001 419 423
69. E. Calikoglu, M. Onder, and B. Cosar Depression, anxiety levels and general psychological profile in Behcet's disease Dermatology 203 2001 238 240
70. M.A. Gupta, and A.K. Gupta Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis Br J Dermatol 139 1998 846 850
71. R. Zachariae, C. Zachariae, and H.H. Ibsen Psychological symptoms and quality of life of dermatology outpatients and hospitalized dermatology patients Acta Derm Venereol 84 2004 205 212
72. V. Niemeier, M. Nippesen, and J. Kupfer Psychological factors associated with hand dermatoses: which subgroup needs additional psychological care? Br J Dermatol 146 2002 1031 1037
73. D.G. Fortune, H.L. Richards, and C.E.M. Griffiths Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia Br J Clin Psychol 41 2002 157 174
74. M.A. Gupta, and A.K. Gupta Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis and chronic idiopathic urticaria Ann N Y Acad Sci 885 1999 394 395
75. A. Reich, J.C. Szepietowski, B. Wisnicka, and P. Pacan Does stress influence itching in psoriatic patients? Dermatol Psychosom 4 2003 151 155
76. M.A. Gupta, A.K. Gupta, and G.N. Watteel Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disorders Cutis 61 1998 339 342
77. A. Picardi, D. Abeni, and C. Renzi Treatment outcome and incidence of psychiatric disorders in dermatological out-patients J Eur Acad Dermatol Venereol 17 2003 155 159
78. G. Schmid-Ott, N. Hofste, and H.-H. Niederauer Illness severity and coping in psoriasis patients: a 1-year follow-up Dermatol Psychosom 5 2004 178 183
79. E. Hammerlid, M. Ahlner-Elmqvist, and K. Bjordal A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients Br J Cancer 80 1999 766 774
80. M.R. Leary, S.R. Rapp, and K.C. Herbst Interpersonal concerns and psychological difficulties of psoriasis patients: effects of disease severity and fear of negative evaluation Health Psychol 17 1998 530 536
81. U. Stangier, A. Ehlers, and U. Gieler Measuring adjustment to chronic skin disorders: validation of a self-report measure Psychol Assess 15 2003 532 549
82. G. Kent, and S. Keohane Social anxiety and disfigurement: the moderating effects of fear of negative evaluation and past experience Br J Clin Psychol 40 2001 23 34
83. L. Williamson, N. Dalbeth, and J.L. Dockerty Nail disease in psoriatic arthritis-clinically important, potentially treatable and often overlooked Rheumatol 43 2004 790 794
84. D.G. Fortune, H.L. Richards, and C.E.M. Griffiths Targeting cognitive-behaviour therapy to patients' implicit model of psoriasis: results from a patient preference controlled trial Br J Clin Psychol 43 2004 65 82
85. D.G. Fortune, H.L. Richards, and A. Corrin Attentional bias for psoriasis-specific and psychosocial threat in patients with psoriasis J Behav Med 26 2003 211 224
86. D.G. Fortune, H.L. Richards, and B. Kirby A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy Br J Dermatol 146 2002 458 465
87. D.G. Fortune, H.L. Richards, and C.E.M. Griffiths Worry and pathological worry in patients with psoriasis: cross sectional and longitudinal analyses of the Penn State Worry Questionnaire (PSWQ) in four samples of patients J Clin Psychol Med Settings 12 2005 143 152
88. D.G. Fortune, H.L. Richards, and C.J. Main Developing clinical psychology services in an outpatient dermatology speciality clinic: what factors are associated with non-uptake of the service? Clin Psychol Forum 115 1998 34 36
89. H.L. Richards, D.G. Fortune, and S.L.P. Chong Divergent beliefs about psoriasis are associated with increased psychological distress for patients and their partners J Invest Dermatol 123 2004 49 56
90. M.A. Gupta, and A.K. Gupta Psoriasis and sex: a study of moderately to severely affected patients Int J Dermatol 36 1997 259 262
91. H.L. Richards, D.G. Fortune, and C.J. Main Stigmatization and psoriasis Br J Dermatol 149 2003 209 211
92. G. Schmid-Ott, B. Jaeger, and H.W. Kuensebeck Dimensions of stigmatization in patients with psoriasis in a "Questionnaire on Experience with Skin Complaints" Dermatologyg 193 1996 304 310
93. G. Schmid-Ott, H.W. Kuensebeck, and B. Jaeger Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients Acta Derm Venereol 79 1999 443 447
94. Y. Lu, P. Duller, and P.G.M. van der Valk Helplessness as predictor of perceived stigmatization in patients with psoriasis and atopic dermatitis Dermatol Psychosom 4 2003 146 150
95. I.A. Rubino, A. Sonnino, and B. Pezzarossa Personality disorders and psychiatric symptoms in psoriasis Psychol Rep 77 1995 547 553
96. I. Fukunishi, and D. Berger Personality disorders and psychiatric symptoms in psoriasis: a critical analysis Psychol Rep 79 1996 1248 1250
97. D. Berger, and I. Fukunishi Personality disorders in psoriasis Psych Rep 80 1997 877 878
98. M.A. Gupta, A.K. Gupta, and G.N. Watteel Early onset (<40 years age) psoriasis is comorbid with greater psychopathology than late onset psoriasis: a study of 137 patients Acta Derm Venereol 76 1996 464 466
99. A. Picardi, P. Pasquinnni, and M.S. Cattaruzza Only limited support for a role of psychosomatic factors in psoriasis: results from a case control study J Psychosom Res 55 2003 189 196
100. H.L. Richards, D.G. Fortune, and C.E.M. Griffiths Alexithymia in patients with psoriasis: clinical correlates and psychometric properties of the Toronto Alexithymia Scale-20 J Psychosom Res 58 2005 89 96
101. D.G. Fortune, H.L. Richards, and C.E.M. Griffiths Adversarial growth in patients undergoing treatment for psoriasis: a prospective study of the ability of patients to construe benefits from negative events Psychol Health Med 10 2005 44 56
102. S. Blok, W.H. Vissers, and M. van Duijnhoven Aggravation of psoriasis by infections: a constitutional trait or a variable expression? Eur J Dermatol 14 2004 259 261
103. B.S. Park, and J.I. Youn Factors influencing psoriasis: an analysis based upon the extent of involvement and clinical type J Dermatol 25 1998 97 102
104. E. Suljagic, O. Sinanovic, and E. Tupkovic Stressful life events and psoriasis during the war in Bosnia Dermatol Psychosom 1 2000 56 60
105. M.A. Gupta, and A.K. Gupta The psoriasis life stress inventory: a preliminary index of psoriasis related stress Acta Derm Venereol 75 1995 240 243
106. R.J. Harvima, H. Viinamaki, and I.T. Harvima Association of psychic stress with clinical severity and symptoms of psoriatic patients Acta Derm Venereol 76 1996 467 471
107. P. Pacan, J.C. Szepietowski, and A. Kiejna Stressful life events and depression in patients suffering from psoriasis vulgaris Dermatol Psychosom 4 2003 142 145
108. L. Naldi, L. Peli, and F. Parazzini Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: results of a case-control study J Am Acad Dermatol 44 2001 433 438
109. J. Kupfer, V. Niemeier, and B. Brosig Sense of coherence among psoriatics as a predictor of symptom-free time following dermatological inpatient therapy Dermatol Psychosom 4 2003 200 206
110. Richards H.L., Ray D.W., Kirby B., et al. The HPA response to psychological stress in patients with psoriasis. Br J Dermatol, in press
111. G. Schmid-Ott, R. Jacobs, and B. Jäger Stress-induced endocrine and immunological changes in psoriasis patients and healthy controls Psychother Psychosom 67 1998 37 42
112. V. Thaller, M. Vrkljan, and L. Hotujac The potential role of hypocortisolism in the pathophysiology of PTSD and psoriasis Colleg Antropol 23 1999 611 619
113. G. Schmid-Ott, B. Jaeger, and C. Adamek Acute psychosocial stress and T-cell response in patients with atopic dermatitis psoriasis, and healthy controls J Psychosom Res 48 2000 249 250
114. R. Zachariae, H. Oster, and P. Bjerring Effects of psychologic intervention on psoriasis: a preliminary report J Am Acad Dermatol 34 1996 1008 1015
115. J. Kabat-Zinn, E. Wheeler, and T. Light Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA) Psychosom Med 60 1998 625 632
116. S. Scheewe, S. Schmidt, and F. Petermann Long-term efficacy of an inpatient rehabilitation with integrated patient education program for children and adolescents with psoriasis Dermatol Psychosom 2 2001 16 21
117. T. Kang Seng, and T. Siew Nee Group therapy: a useful and supportive treatment for psoriasis patients Int J Dermatol 36 1997 110 112
118. I. Lazaroff, and R. Shismshoni Effects of medical resonance therapy music on patients with psoriasis and neurodermatitis-a pilot study Integrat Physiol Behav Sci 35 2000 189 198
119. F. Tausk, and S.E. Whitmore A pilot study of hypnosis in the treatment of patients with psoriasis Psychother Psychosom 68 1999 221 225
120. S.C. Weiss, A.B. Kimball, and D.J. Liewehr Quantifying the harmful effect of psoriasis on health-related quality of life J Am Acad Dermatol 47 2002 512 518
121. J. Koo Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment Dermatol Clin North Am 14 1996 485 496